In 2023, the export of insulin in dosage forms from China stood at 1.03 million kilograms. Forecasted data from 2024 to 2028 shows a consistent upward trend: 2024 (1.0717 million kg), 2025 (1.1216 million kg), 2026 (1.1705 million kg), 2027 (1.2185 million kg), and 2028 (1.2654 million kg). Year-on-year percentage variations show steady increases: 2025 (+4.65%), 2026 (+4.35%), 2027 (+4.10%), and 2028 (+3.85%). The Compound Annual Growth Rate (CAGR) over the last five years is approximately 4.90%.
Future trends to watch for include advancements in biotechnology, potential export market expansion driven by increasing global diabetes prevalence, and competitive dynamics with other insulin-producing nations.
